Oxford Biomedica (OXB) Stock Chart & Stock Price History GBX 345 -30.00 (-8.00%) As of 02/21/2025 12:16 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Oxford Biomedica Stock Price Performance 5 Day Performance-11.31%1 Month Performance-16.87%3 Month Performance-17.86%6 Month Performance-0.43%Year-To-Date Performance-17.86%1 Year Performance+103.42% Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address OXB Stock Chart for Saturday, February, 22, 2025 OXB Chart by TradingView Oxford Biomedica Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 375GBX 345-8.00%GBX 373.50GBX 342.50361,349 shs£366.74 million02/20/2025GBX 382GBX 375-1.83%GBX 386.50GBX 374405,475 shs£398.63 million02/19/2025GBX 387GBX 382-1.29%GBX 390GBX 378.50281,528 shs£406.07 million02/18/2025GBX 389GBX 387-0.51%GBX 390.50GBX 381.50176,416 shs£411.39 million02/17/2025GBX 390GBX 389-0.26%GBX 392.50GBX 369315,157 shs£413.51 million02/14/2025GBX 390GBX 390GBX 398.50GBX 384.5096,220 shs£414.57 million02/13/2025GBX 391GBX 390-0.26%GBX 398.50GBX 372.50126,541 shs£414.57 million02/12/2025GBX 395GBX 391-1.01%GBX 403GBX 390201,486 shs£411.96 million02/11/2025GBX 395GBX 395GBX 398GBX 390162,111 shs£416.17 million02/10/2025N/AGBX 395GBX 401GBX 393213,410 shs£416.17 million Get the Latest News and Ratings for OXB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 405GBX 399.50-1.36%GBX 407GBX 399.50218,943 shs£420.91 million02/06/2025GBX 409GBX 405-0.98%GBX 413GBX 403148,024 shs£426.71 million02/05/2025GBX 410GBX 409-0.24%GBX 424.50GBX 406.50343,494 shs£430.92 million02/04/2025GBX 405GBX 410+1.23%GBX 413.50GBX 400155,898 shs£431.98 million02/03/2025GBX 417GBX 405-2.88%GBX 414.50GBX 405130,973 shs£426.71 million01/31/2025GBX 413GBX 417+0.97%GBX 426.50GBX 410.50194,082 shs£439.35 million01/30/2025GBX 423GBX 413-2.36%GBX 424GBX 411.50105,067 shs£435.14 million01/29/2025GBX 444GBX 423-4.73%GBX 450GBX 421.50128,219 shs£445.67 million01/28/2025GBX 415.50GBX 444+6.86%GBX 454.50GBX 415467,163 shs£467.80 million01/27/2025GBX 415GBX 415.50+0.12%GBX 417.50GBX 4121.13 million shs£437.77 million01/24/2025GBX 416.78GBX 415-0.43%GBX 423GBX 413.5063,188 shs£437.24 million01/23/2025GBX 415GBX 416.78+0.43%GBX 421.50GBX 412.86170,424 shs£439.11 million01/22/2025GBX 415GBX 415GBX 423GBX 410117,261 shs£437.24 million01/21/2025GBX 405GBX 415+2.47%GBX 417.50GBX 404.50117,912 shs£437.24 million Related Companies Oxford Nanopore Technologies Stock Price Chart Genus Stock Price Chart PureTech Health Stock Price Chart Avacta Group Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart hVIVO Stock Price Chart Scancell Stock Price Chart Futura Medical Stock Price Chart Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OXB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.